Precision Therapy for Advanced Cholangiocarcinoma: Focus on FGFR Inhibitors

Share

Program Content

  • Precision Therapy for Advanced Cholangiocarcinoma: Focus on FGFR Inhibitors
    Precision Therapy for Advanced Cholangiocarcinoma: Focus on FGFR Inhibitors
    Expert Insights
    Congratulations: You achieved a completion on 04/09/2022
    View Activity

Faculty

cover img faculity

Philip A. Philip, MD, PhD, FRCP

Professor
School of Medicine
Wayne State University
Leader
Gastrointestinal Multidisciplinary Team
Department of Oncology
Henry Ford Cancer Institute
Detroit, Michigan

Provided by

ProCE Banner